Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A retinopathy caused by biallelic variants in the LCA5 gene.
Biomarker and diagnostic research for LCA5-related retinopathy has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include biologic therapy. Pipeline includes 1 PHASE1. Research is primarily industry-sponsored.
209 publications have been identified in PubMed for LCA5-related retinopathy. Kisho has analyzed 147 by research type. Research spans Review / Meta-Analysis (34%), Basic Science / Preclinical (30%), and Epidemiology / Natural History (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 50 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:36 AM UTC
Common questions about LCA5-related retinopathy
Laboratory research | 44 | 30% |
Disease patterns and progression | 15 | 10% |
New treatment approaches | 12 | 8% |
Testing and diagnosis research | 10 | 7% |
Patient case studies | 8 | 5% |
Clinical study results | 7 | 5% |
Other research | 1 | 1% |
Zhao CS (2026). [PMID: 41608829](https://pubmed.ncbi.nlm.nih.gov/41608829/). *Curr Opin Ophthalmol*. [Review / Meta-Analysis]
Marmor MF (2026). [PMID: 41232611](https://pubmed.ncbi.nlm.nih.gov/41232611/). *Ophthalmology*. [Review / Meta-Analysis]
Niaudet C (2026). [PMID: 41271176](https://pubmed.ncbi.nlm.nih.gov/41271176/). *Radiother Oncol*. [Review / Meta-Analysis]
Land MR (2026). [PMID: 41750360](https://pubmed.ncbi.nlm.nih.gov/41750360/). *Biomolecules*. [Review / Meta-Analysis]
Selim MS (2026). [PMID: 41827851](https://pubmed.ncbi.nlm.nih.gov/41827851/). *Cells*. [Review / Meta-Analysis]
Ning J (2026). [PMID: 41135636](https://pubmed.ncbi.nlm.nih.gov/41135636/). *Biochim Biophys Acta Mol Basis Dis*. [Basic Science / Preclinical]
Wang X (2026). [PMID: 41662529](https://pubmed.ncbi.nlm.nih.gov/41662529/). *Proceedings of the National Academy of Sciences of the United States of America*. [Basic Science / Preclinical]
Mukundan A (2026). [PMID: 41316839](https://pubmed.ncbi.nlm.nih.gov/41316839/). *Ocular immunology and inflammation*. [Case Report / Case Series]
Hang C (2026). [PMID: 41448484](https://pubmed.ncbi.nlm.nih.gov/41448484/). *American journal of ophthalmology*. [Basic Science / Preclinical]
Pavlou M (2026). [PMID: 42020901](https://pubmed.ncbi.nlm.nih.gov/42020901/). *Methods Mol Biol*. [Gene Therapy / Novel Therapeutics]